/newsnation-english/media/agency_attachments/2024-07-23t155806234z-logo-webp.webp){kind=logo}
Doxylamine and Pyridoxine
/newsnation-english/media/media_files/media/details/ANI-20250809051243-664365.jpg)
Akums Reports Q1 FY26 with 19% YoY Adj EBITDA Growth; Achieves 1,000 DCGI Approvals
Aug 09, 2025
10:50
IST
3 Min read
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news